Search

Your search keyword '"United States. National Institute of Diabetes and Digestive and Kidney Diseases"' showing total 12 results
Start Over Descriptor "United States. National Institute of Diabetes and Digestive and Kidney Diseases" Publisher right vision media
12 results on '"United States. National Institute of Diabetes and Digestive and Kidney Diseases"'

1. Dignify Therapeutics awarded two new research grants from the National Institutes of Health (NIH)

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, United States. National Institutes of Health, United States. National Institute on Aging, Research grants, Grants-in-aid, Gastrointestinal diseases, Company financing, General interest, News, opinion and commentary
Abstract

RESEARCH TRIANGLE PARK, N.C.: Dignify Therapeutics has issued the following news release: Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, recently received two significant research [...]

Published
2024

2. Enable Biosciences Receives $3M Phase IIB SBIR Award from NIDDK for Advanced T1D Testing Technology

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, Autoimmunity, Biological products, Type 1 diabetes, Kidney diseases, General interest, News, opinion and commentary
Abstract

SOUTH SAN FRANCISCO: Enable Biosciences Inc has issued the following news release: Enable Biosciences Inc., a leader in diagnostic technologies, is elated to announce its receipt of a Phase IIB [...]

Published
2023

3. PREVISE FUELS GROWTH OF ITS BARRETT'S ESOPHAGUS RISK STRATIFICATION TEST WITH A COMPETITIVE $1.8M SBIR GRANT

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, United States. National Institutes of Health, Methylation, Medical colleges, Company financing, General interest, News, opinion and commentary
Abstract

BALTIMORE: Previse has issued the following news release: Previse, maker of Esopredict, a clinically available test that analyzes methylation of biomarkers to assess the risk of esophageal cancer developing in [...]

Published
2023

4. National Institutes of Health To Locate Signature Research Program on the Phoenix Bioscience Core

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, United States. National Institutes of Health, Medical research, Medicine, Experimental, Biotechnology, Biotechnology industry, Epidemiology, Kidney diseases, Type 2 diabetes, General interest, News, opinion and commentary
Abstract

PHOENIX: Phoenix Bioscience Core has issued the following news release: Wexford Science & Technology, LLC today announced that the National Institutes of Health has signed a lease at 850 PBC [...]

Published
2023

5. PLAMECA's QUICKISEN is a Natural Solution to Constipation

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, Sennosides, Constipation, General interest, News, opinion and commentary
Abstract

FORT LAUDERDALE, Fla: Plameca has issued the following news release: Constipation is a common concern among all Americans. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) explains [...]

Published
2023

6. The American Diabetes Association Welcomes 2023 Principal Officers and New Members to the National Board of Directors

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, Societies, Boards of directors, Type 2 diabetes, Associations, institutions, etc., General interest, News, opinion and commentary, American Diabetes Association
Abstract

ARLINGTON: American Diabetes Association has issued the following news release: The American Diabetes Association(r) (ADA) welcomes the 2023 Principal Officers and Board of Directors. The 13-member board is comprised of [...]

Published
2023

7. OrsoBio Announces Exclusive License to Intellectual Property Relating to Mitochondrial Protonophores for the Treatment of Severe Metabolic Disorders

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, Intellectual property, Type 2 diabetes, Intellectual property, General interest, News, opinion and commentary, Yale University -- Intellectual property
Abstract

PALO ALTO: ORSOBIO, INC. has issued the following news release: OrsoBio, Inc., a clinical-stage biopharmaceutical company developing treatments for severe metabolic disorders, today announced that it has acquired exclusive worldwide [...]

Published
2022

8. AmideBio Awarded SBIR Phase IIB Grant to Support Pre-Clinical Development of its Long-Acting Stable Glucagon Analog for the Treatment of Hyperinsulinism

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, Glucagon, General interest, News, opinion and commentary
Abstract

BOULDER: AmideBio, LLC has issued the following news release: AmideBio, LLC, a privately held biopharmaceutical company, announced today that it has received $2.69M in funding through a Phase IIB Small [...]

Published
2022

9. Imagine Pharma Awarded Contract from National Institute of Diabetes and Digestive and Kidney Diseases's Integrated Islet Distribution Program to Provide Human Islets

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, Social service, Kidney diseases, Contract agreement, General interest, News, opinion and commentary
Abstract

PITTSBURGH: Imagine Pharma/Zero to Five has issued the following news release: Imagine Pharma, a biotechnology company focused on the development of its novel polypeptide (IMG-1) across three distinct platforms: Oral [...]

Published
2022

10. DLH Wins Renewal of National Institute of Health Contract for Epidemiologic and Public Health Support

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, United States. National Institutes of Health, Natural language interfaces, Public health, Computational linguistics, Language processing, Kidney diseases, Contract agreement, General interest, News, opinion and commentary
Abstract

ATLANTA: DLH Holdings Corp. has issued the following press release: DLH Holdings Corp. (NASDAQ: DLHC) ('DLH' or the 'Company'), a leading health and human services provider to the federal government, [...]

Published
2022

11. Dovel Subsidiary, Medical Science & Computing, LLC (MSC) Awarded NIH NIDDK IDIQ

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, United States. National Institutes of Health, Kidney diseases, General interest, News, opinion and commentary
Abstract

MCLEAN: Dovel Technologies has issued the following news release: Dovel Technologies announced today that its subsidiary Medical Science & Computing, LLC (MSC) has been awarded a multi-award Indefinite Delivery Indefinite [...]

Published
2021

12. Brillient Receives NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Multi-Award IDIQ

Subjects
United States. National Institute of Diabetes and Digestive and Kidney Diseases, United States. National Institutes of Health, United States. Eunice Kennedy Shriver National Institute of Child Health and Human Development, Medical research, Medicine, Experimental, Kidney diseases, General interest, News, opinion and commentary
Abstract

RESTON: Brillient Corporation has issued the following news release: Brillient Corporation announced today that the NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and Eunice Kennedy Shriver [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results